Emmanuelle di Tomaso
Bayer (United States)(US)
Publications by Year
Research Areas
PI3K/AKT/mTOR signaling in cancer, Angiogenesis and VEGF in Cancer, HER2/EGFR in Cancer Research, Glioma Diagnosis and Treatment, Advanced Breast Cancer Therapies
Most-Cited Works
- → Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer(2004)1,946 cited
- → AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients(2007)1,760 cited
- → Angiogenesis in brain tumours(2007)1,377 cited
- → Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation(2004)1,173 cited
- → Lymphatic Metastasis in the Absence of Functional Intratumor Lymphatics(2002)961 cited
- → Cancer cells compress intratumour vessels(2004)843 cited
- Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions.(2000)
- → Mosaic blood vessels in tumors: Frequency of cancer cells in contact with flowing blood(2000)666 cited
- → Herceptin acts as an anti-angiogenic cocktail(2002)631 cited
- → Role of tumor–host interactions in interstitial diffusion of macromolecules: Cranial vs. subcutaneous tumors(2001)591 cited